What Research Does LCFA Fund and Who Are Its Researchers?

The Lung Cancer Foundation of America (LCFA) funds transformative lung cancer research aimed at improving survivorship, and its site highlights both established and early-career researchers working on tumor mapping, immune response, and immunotherapy. The clearest way to see what LCFA funds is to look at the researchers it features and the specific questions their projects address — from locating cancer-fighting cells inside tumors to understanding immune activity in early-stage disease.

What LCFA says its research mission is

LCFA describes its mission as "dedicated to improving survivorship by funding transformative lung cancer research." That framing matters: the foundation presents research funding as the path to better patient outcomes, not as an end in itself. The site reinforces this with patient voices, including survivor Brandi Bryant's line, "Research is HOPE," and Co-Founder and President Kim Norris's statement that donor support is "shaping future leaders in lung cancer research."

Researchers and projects featured on the site

The "Meet the Researchers" section lists specific investigators with a short description of each project. The examples shown on the page:

These three examples show the range of LCFA's research interests: spatial mapping of immune cells within tumors, immune checkpoint biology in early-stage non-small cell lung cancer, and immunology lab work more broadly. The site also references "Immunotherapy in Early Stage Lung Cancer" as a research theme.

Support for early-career researchers

LCFA's "Young Investigator" program is visible in the site's materials. Dr. Christine Lovly, identified as an "LCFA Young Investigator," is quoted saying, "There is such tremendous hope for all patients with lung cancer right now." The foundation frames this support as building future research leaders — the same idea behind the statement that generosity is "shaping future leaders in lung cancer research." If you want to know which specific investigators currently hold Young Investigator awards, the "Meet the Researchers" and "View all" links on the site are the place to check, since the homepage shows only a sample.

How the research connects to treatment advances

The site ties funded research directly to evolving treatment options. Its featured article, "Small Cell Lung Cancer Treatments Are Evolving," notes that "chemotherapy is no longer the only option for small cell lung cancer" and that "from immunotherapies to clinical trials, groundbreaking research is expanding choices and helping patients live better." This is the clearest statement on the page of the mechanism LCFA is betting on: research funding → new treatment options → better and longer lives for patients.

The survivor stories on the site echo the same link. Featured stories carry tags such as biomarker testing, targeted therapy, EGFR, ALK+, and immunotherapy-adjacent topics — the areas where research is changing what a diagnosis means. For example, Michelle's story is tagged with biomarker testing and targeted therapy, and Jeff Stibelman's story with EGFR and stage 4 targeted therapy.

If you want to follow or evaluate LCFA's research

• To see current projects: start with the "Meet the Researchers" section and use "View all" to browse beyond the homepage sample.
• To follow progress: the site offers a monthly email newsletter with "inspiring stories, groundbreaking research, and the early career researchers you're helping to support," plus Facebook updates.
• To judge fit: compare the listed projects against your interest — the current examples lean toward tumor immunology, immune cell mapping, and early-stage NSCLC immune response rather than, say, screening policy or epidemiology.

The site does not publish grant amounts, application deadlines, or a full funded-project database on the pages shown here, so for those details you would need to check LCFA's research or grant pages directly rather than infer them from the homepage.